ClinicalTrials.Veeva

Menu

High Flow Nasal Cannula Rates in Pediatric Asthma

University of Rochester logo

University of Rochester

Status

Invitation-only

Conditions

Pediatric Asthma

Treatments

Device: "High Flow" High Flow Nasal Cannula
Device: "Low Flow" High Flow Nasal Cannula

Study type

Interventional

Funder types

Other

Identifiers

NCT06379607
STUDY00009285

Details and patient eligibility

About

This is a randomized, open-label, 3-armed feasibility trial will examine conventional oxygen therapy (COT) vs high flow nasal cannula at 4L/min flow vs HFNC at 2L/kg/min flow (max 60L/min) in moderate to severe pediatric asthma exacerbations.

Full description

The purpose of this feasibility trial is to examine the safety and efficacy of high flow nasal cannula in moderate to severe pediatric asthma exacerbations. Eligible patients will be admitted to the Pediatric Intensive Care Unit (PICU) after initial presentation to the emergency department (ED) or as a transfer from an outside hospital ED. Patients will be admitted to the PICU on standard asthma therapy (continuous albuterol and systemic corticosteroids) based on the discretion of the treating ED physician. Upon PICU admission, eligible patients will be consented, enrolled, and randomized into the study. All patients will be continued on standard asthma therapy of continuous albuterol at 20mg/hr and systemic intravenous corticosteroids. Patient will be randomized into one of three groups: (1) conventional oxygen therapy at 2L/min via standard facemark (control group), (2) high flow nasal cannula at 4L/min, and (3) high flow nasal cannula at 2L/kg/min (max 60L/min). Pediatric Respiratory Assessment Measure (PRAM) scores and vital signs will be taken at baseline and hourly for two hours. After the two-hour long study is completed, patients will be placed on a respiratory support modality as per the treating physician's discretion. Patients will be followed longitudinally after study completion.

Enrollment

27 estimated patients

Sex

All

Ages

2 to 17 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 2-17 years old with prior clinical diagnosis of asthma
  • Admitted to PICU on standard asthma therapy defined as continuous albuterol and systemic corticosteroids
  • Admitted to PICU on either COT or HFNC
  • Admitted to PICU from either Golisano Children's Hospital ED or as a transport from an outside hospital ED within 6 hours of initial presentation
  • PRAM score greater than or equal to 4 after completion of initial ED therapy

Exclusion criteria

  • Admitted to the PICU on NIV or invasive mechanical ventilation
  • Admitted to the PICU from general floors or > 6 hours from initial presentation
  • Presence of a tracheostomy or baseline NIV requirement
  • Pregnancy
  • Immunocompromised State

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

27 participants in 3 patient groups

Conventional Oxygen Therapy (COT)
No Intervention group
Description:
Conventional Oxygen Therapy (COT) is the standard way to deliver oxygen to hypoxemic pediatric patients during an acute asthma exacerbation. Continuous albuterol will be administered via an aerogen set-up (aerogen mask, aerogen ultra, and a vibrating mesh nebulizer). Oxygen tubing will be connected to the wall and run at 2L/min as per the aerogen manufacturer's instructions.
"Low Flow" High Flow Nasal Cannula at 4L/min
Experimental group
Description:
A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 4L/min and patient will be fitted with appropriately sized nasal prongs.
Treatment:
Device: "Low Flow" High Flow Nasal Cannula
"High Flow" High Flow Nasal Cannula at 2L/kg/min (max 60L/min)
Experimental group
Description:
A Fisher Paykl humidifier will be used for high flow humidification along with a flow meter and oxygen blender. A vibrating mesh nebulizer will be connected between the flow meter and the humidifier as per routine practice. Oxygen flow will be set to 2L/kg/min (max 60L/min) and patient will be fitted with appropriately sized nasal prongs.
Treatment:
Device: "High Flow" High Flow Nasal Cannula

Trial contacts and locations

2

Loading...

Central trial contact

Michele E Smith, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems